⚡ Key Takeaways
- Specialty drug tier placement varies by plan; the same drug may be Tier 4 on one Connecticut plan and Tier 5 on another, with thousands of dollars in cost-sharing difference.
- Connecticut
- Connecticut prohibits copay accumulator adjusters on fully insured commercial plans, allowing manufacturer copay assistance to count toward the patient
- Anthem PPO offers the broadest oncology network including Smilow, MSK, Dana-Farber, and NewYork-Presbyterian; ConnectiCare HMO and UnitedHealthcare EPO are more restricted.
- A private broker pulls the full formulary, verifies the specialty pharmacy network, enrolls the patient in manufacturer copay programs, and monitors quarterly formulary updates.
Key Takeaways
The 2026 Connecticut Chronic-Condition Coverage Landscape
Sources: Access Health CT 2026 Plans, Yale New Haven Health
Sources: CMS Medicare Drug Price Negotiation, FDA Biosimilars
Sources: CT Insurance Dept
Formulary Tiers and Specialty Drug Coverage
Sources: Vertex GPS Patient Support
Prior Authorization and Step Therapy: The Hidden Restrictions
Sources: AMA Prior Authorization Reform
Oncology Networks: Smilow, Hartford, Memorial Sloan Kettering
Sources: Smilow Cancer Hospital, Memorial Sloan Kettering, NCI Designated Centers
Transplant Coverage and Centers of Excellence
Sources: Yale New Haven Transplant Center, UNOS Transplant Centers
Specialty Pharmacy: Accredo, CVS Specialty, Optum
Sources: CarelonRx, Accredo, CVS Specialty, Optum Specialty
Manufacturer Copay Cards and Accumulator Adjusters
Sources: Humira Complete
Sources: All Copays Count Coalition
Four Real CT Chronic-Condition Scenarios
Scenario 1: The New Haven MS Patient on Ocrevus
Scenario 2: The Hartford Crohn
Scenario 3: The Stamford Breast Cancer Patient (Newly Diagnosed)
Scenario 4: The Greenwich Cystic Fibrosis Family on Trikafta
Why a Private Broker Matters for Chronic Conditions
Get Expert Help Choosing Coverage for Your Condition
Frequently Asked Questions
What is the difference between Tier 4 and Tier 5 specialty drug placement?
Tier 4 (preferred specialty) typically has lower patient cost-sharing — often a fixed dollar copay of $150–$350/month or 20–30% coinsurance with a monthly cap. Tier 5 (non-preferred specialty) typically uses higher coinsurance (30–50%) without a monthly cap, exposing the patient to potentially thousands of dollars per month until the annual out-of-pocket maximum is reached. The same drug may be Tier 4 on one Connecticut plan and Tier 5 on another, so verifying tier placement before enrollment is essential for chronic-condition patients.
Does Connecticut prohibit copay accumulator adjusters?
Yes, for fully insured commercial plans sold in Connecticut. House Bill 6710 (effective 2024) requires manufacturer copay assistance to count toward the patient’s deductible and out-of-pocket maximum on most state-regulated commercial plans. The prohibition does not extend to self-funded ERISA plans, which many large Connecticut employers use. The broker confirms whether a specific plan is fully insured (subject to the prohibition) or self-funded (not subject) before enrollment.
Can I switch specialty pharmacies if I
Only by changing insurance carriers. Most Connecticut commercial plans require specialty drugs to be filled through a specific contracted specialty pharmacy network — Anthem uses CarelonRx Specialty, ConnectiCare uses CVS Caremark Specialty, UnitedHealthcare uses Optum Specialty. The patient cannot self-select an alternative specialty pharmacy within the same plan. Carrier selection during Open Enrollment effectively chooses the specialty pharmacy for the year.
What if my plan requires step therapy and the alternative drug doesn
Connecticut’s step-therapy override law (CGS 38a-510b) allows your prescribing physician to file an override request when the required alternative is contraindicated, expected to be ineffective, previously failed, or when you are stable on the requested drug. The carrier must respond within 72 hours. The broker assists with the override submission and tracks the deadline; if the carrier misses the deadline, the request is deemed approved under Connecticut’s 2024 prior-auth reform law.
Does my Anthem PPO cover treatment at Memorial Sloan Kettering or Dana-Farber?
Yes, for most Anthem PPO plans sold in Connecticut. Anthem’s national BlueCard PPO network includes Memorial Sloan Kettering (NYC) and Dana-Farber Cancer Institute (Boston) as in-network providers. ConnectiCare HMO and UnitedHealthcare Oxford EPO generally do not include these out-of-state cancer centers as in-network. For Connecticut residents who may need referral to MSK or Dana-Farber, Anthem PPO is typically the optimal plan choice.
Are CAR-T therapies and gene therapies covered by Connecticut commercial plans?
Yes, all FDA-approved CAR-T therapies (Yescarta, Kymriah, Tecartus, Breyanzi, Carvykti, Abecma) and gene therapies (Zolgensma, Luxturna, Casgevy, Lyfgenia, Skysona, Roctavian, Hemgenix) are covered on Connecticut commercial plans when prescribed at FDA-authorized treatment centers. These therapies typically require prior authorization with detailed clinical documentation, are billed under medical benefits (not pharmacy), and are subject to the plan’s out-of-pocket maximum. The broker verifies the in-network status of the authorized treatment center and pre-coordinates the authorization.